Nexomic

Biology, AI Decoded

[Nexomic @Nexomic_]

Molecular Monday | week 5

Inherited or acquired? Driver or passenger?

Not all cancer-related mutations are the same. Here’s the difference. ↓

#MolecularMonday #CancerResearch #Genomics

[Nexomic @Nexomic_]

We are excited to announce a new partnership between Nexomic and Genomics England.

This partnership will enable us to validate DeepOmic, our tumour-agnostic foundation model, using large-scale multi-omics data from cancer patients.

Read more: https://t.co/apki1VcfCi

[Nexomic @Nexomic_]

Announcing a new partnership to de-risk oncology drug development and clinical trials.
Nexomic is partnering with Alpha Clinical Development to bring DECODE, Nexomic’s AI-powered multi-omic intelligence solution, into oncology clinical development programmes.
By combining Alpha Clinical Developments’ clinical trial strategy expertise with Nexomic’s ability to decode the biology of treatment response and resistance, we aim to help sponsors define biologically relevant patient populations and inform trial design, biomarker strategy, patient stratification and enrichment, enabling better development decisions earlier.

Read more: https://t.co/XJdCAeHQbV

[Nexomic @Nexomic_]

Nexomic is pleased to announce Prof. Massimo Cristofanilli as a member of its Advisory Board.

His internationally recognised expertise and leadership in precision oncology will strengthen Nexomic’s mission to translate advanced cancer biology into meaningful clinical impact

[Nexomic @Nexomic_]

Nexomic is pleased to announce Prof. Massimo Cristofanilli as a member of its Advisory Board.

His internationally recognised expertise and leadership in precision oncology will strengthen Nexomic’s mission to translate advanced cancer biology into meaningful clinical impact

[Nexomic @Nexomic_]

Did you know?

Your body makes millions of proteins every second.

These molecules build, repair, communicate, and protect—keeping your body functioning every moment of the day.

Discover why proteins are essential. ↓

#MolecularMonday #Proteomics #PrecisionMedicine

[Nexomic @Nexomic_]

Did you know?

Your body makes millions of proteins every second.

These molecules build, repair, communicate, and protect—keeping your body functioning every moment of the day.

Discover why proteins are essential. ↓

#MolecularMonday #Proteomics #PrecisionMedicine

[Nexomic @Nexomic_]

Proud to share a major scientific milestone for Nexomic.
5 abstracts have been accepted for presentation at ESMO Congress 2026 in Madrid, 23–27 October. The studies showcase our latest innovations in AI-driven precision oncology.

Accepted abstracts:

#2737: A Self-supervised Multi-omic AI Foundation Model Recovers Prognostic Subgroups Across Seven Independent Solid Tumour Cohorts
#7878: A Pretrained Multi-omic AI Foundation Model Identifies Eight Prognostically Distinct Breast Cancer Subgroups in METABRIC
#7766: Pathway-guided Multi-omic AI Reconstructs Missing RNA and DNA Methylation Profiles Across 34 Cancer Types
#7824: DNA-only Multi-omic AI Identifies Tumour Primary Site Across 31 Lineages for Cancer of Unknown Primary
#7967: Multi-omic AI Stratifies Survival in Immunotherapy-treated Metastatic Pancreatic Cancer

This milestone reflects the dedication of Nexomic’s multidisciplinary team and our mission to transform complex multi-omic data into meaningful insights.

Excited to share our work with the global oncology community at ESMO 2026.

[Nexomic @Nexomic_]

Molecular Monday | Part 3 🧬
Every biomarker adds a different piece to the puzzle. Understanding them together is what makes precision medicine possible.

#MolecularMonday #PrecisionMedicine #Biomarkers #MultiOmics #HealthcareAI

[Nexomic @Nexomic_]

Molecular Monday | Part 2

Gene activity can change without changing your DNA.

That’s what epigenomics helps us understand.

#MolecularMonday #Epigenomics #Biotech

[Nexomic @Nexomic_]

Our new website is now live. Explore the future of precision oncology.

https://t.co/SgLlE3E77o

#AI #PrecisionOncology

[Nexomic @Nexomic_]

Nexomic is pleased to announce @alshamsi2000 as Chairman.

His leadership strengthens Nexomic’s mission to advance AI-driven precision oncology and transform the future of cancer care.

[OncoDaily @oncodaily]

Happy to Start a New Position as Chairman at Nexomic - Humaid Al-Shamsi (@alshamsi2000)

@Nexomic_

https://t.co/LZqmzd9ci7

[Nexomic @Nexomic_]

Precision medicine requires more than genomics.

Multi-omics is expanding how we understand disease by bringing together multiple layers of biology. At Nexomic, we’re combining these data with AI to help turn molecular complexity into actionable insights

#multiomics

[Nexomic @Nexomic_]

Not all cancers start in organs.

This July, for Sarcoma & Bone Cancer Awareness Month, we’re spotlighting rare cancers that begin in bone and soft tissue, and why deeper molecular insight matters for more precise cancer care.

#SarcomaAwareness #BoneCancerAwareness

[Nexomic @Nexomic_]

Molecular Monday — Part 1

What does “molecular” mean in cancer care?

At Nexomic, we’re breaking down the science behind precision oncology, one concept at a time.

More molecular insight. Better cancer decisions.

#Nexomic #MolecularMonday #PrecisionOncology #CancerCare

[AI Ireland @AIAwardsIrl]

Congratulations to our amazing nominees that been been chosen by our judging panel in the #WomeninAI Ambassador of the Year award for the 2025 #AIAwardsIRL

The finalists are:
Ghadeer Ghosheh @Nexomic_
Maryrose Lyons
Mithra Ravichandran
Swati Narsinghani @ICONplc

[Nexomic @Nexomic_]

Follow along as we build the next era of biological intelligence.

Follow us for updates, connect with us, and visit our website: https://t.co/WjBFFgoiTe
#Biotech #AI #MultiOmics #SystemsBiology #NexGen #PrecisionMedicine

[Nexomic @Nexomic_]

Not your typical Biotech Company

At Nexomic, we’re building AI-native, systems-biology solutions to make sense of complex heterogeneous diseases. Learning latent biology, unifying multi-omics through a mechanistic lens, and translating those discoveries into actionable insights.